SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041014
Filing Date
2019-11-06
Accepted
2019-11-06 16:11:54
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20190930.htm 10-Q 2970592
2 EX-31.1 ubx-ex311_8.htm EX-31.1 18081
3 EX-31.2 ubx-ex312_9.htm EX-31.2 18064
4 EX-32.1 ubx-ex321_6.htm EX-32.1 14624
  Complete submission text file 0001564590-19-041014.txt   8492475

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ubx-20190930.xml EX-101.INS 1771916
6 XBRL TAXONOMY EXTENSION SCHEMA ubx-20190930.xsd EX-101.SCH 53587
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20190930_cal.xml EX-101.CAL 44372
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20190930_def.xml EX-101.DEF 182041
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20190930_lab.xml EX-101.LAB 391505
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20190930_pre.xml EX-101.PRE 316276
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 191196417
SIC: 2834 Pharmaceutical Preparations